SCHEMBL8305540

SCHEMBL8305540

C/C(=N/OCCO)c1ccc(-c2ccc3c(c2)OCO3)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 2/20 0.46
GABRB2 P47870 2/20 0.46
KMT2A Q03164 5/20 0.41
MAPT P10636 5/20 0.41
GAA P10253 1/20 0.41
HTT P42858 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
TP53 P04637 1/20 0.39
KCNH2 Q12809 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
MEN1 O00255 2/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
CA12 O43570 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8305543 1.00 GABRA1 (0.46) GABRA1GABRB2KMT2AMAPTGAA
SCHEMBL8686060 0.78 GABRA1 (0.46) GABRA1GABRB2KMT2AMAPTNPC1
SCHEMBL5610797 0.76 LMNA (0.56) MAPTHTTL3MBTL1NPC1RAB9A
SCHEMBL5610798 0.76 LMNA (0.56) MAPTHTTL3MBTL1NPC1RAB9A
SCHEMBL8309932 0.76 PPARA (0.48) HTTL3MBTL1SMN1; SMN2LMNA
SCHEMBL8309933 0.76 PPARA (0.48) HTTL3MBTL1SMN1; SMN2LMNA
SCHEMBL5609899 0.75 LMNA (0.65) MAPTHTTL3MBTL1RAB9ASMN1; SMN2
SCHEMBL5609892 0.75 LMNA (0.65) MAPTHTTL3MBTL1RAB9ASMN1; SMN2
SCHEMBL8443076 0.74 LMNA (0.42) HTTL3MBTL1SMN1; SMN2LMNA
SCHEMBL5609817 0.74 PPARG (0.50) MAPTHTTL3MBTL1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed